超性液体:一种潜在的方法来减少超吸收性聚合物珠子与儿童相关的肠道阻塞
Brian C Gulack1, Jacky Kwong2, Gwyneth Sullivan2
1Division of Pediatric Surgery, Department of Surgery, Rush University Medical Center, 1725 West Harrison Street, Professional Building Suite 710, Chicago, IL, 60612, USA. brian_gulack@rush.edu.
Pediatric surgery international
|April 30, 2025
概括
某些高性液体,如果汁和Gastrografin,可以防止超吸收聚合物 (SAP) 珠子的生长和收缩. 这可能有助于在儿童摄入后预防小肠阻塞 (SBO).
科学领域:
- 儿科胃肠病学 儿科胃肠病学
- 毒理学 毒理学 毒理学
- 材料科学 材料科学 材料科学
背景情况:
- 超吸收性聚合物 (SAP) 珠子存在小肠阻塞 (SBO) 的风险,如果儿童摄入.
- 有限的数据存在于管理由SAP珠子摄入引起的儿科SBO.
- 超性液体被假设可以减轻SAP珠子的生长,并防止SBO.
研究的目的:
- 调查各种高性液体在限制SAP珠子生长方面的有效性.
- 为了确定超性液体是否可以诱导预水的SAP珠的收缩.
- 评估潜在的基于液体的干预措施,以防止SAP珠子摄入后的SBO.
主要方法:
- 测试了一系列高性液体,包括100%的果汁,矿物油,Gastrografin等.
- 模拟的肠液作为对照进行了比较.
- 在24小时的补水后,使用回归分析量化了SAP珠子的生长和收缩.
主要成果:
- 与对照组相比,矿物油,Gastrografin和100%的果汁显著抑制了SAP珠子的生长.
- 百分之百的果汁在缩小预制水的SAP珠子方面表现出最大的有效性.
- 统计分析证实了这些发现的意义 (p < 0.001).
结论:
- 胃谱和100%的果汁在食用后控制SAP珠子大小方面表现有前途.
- 使用这些药物的基于液体的协议可以预防SBO并减少对手术的需要.
- 需要进一步的临床评估来确认这些发现的治疗潜力.
相关概念视频
Drugs Affecting GI Tract Motility: Other Laxatives
122
Laxatives are primarily used to alleviate constipation, a common gastrointestinal disorder characterized by infrequent bowel movements and difficulty passing stools. They work by various mechanisms to increase the volume or frequency of bowel movements. The primary modes of action of laxatives include increasing stool bulk, softening the stool, stimulating intestinal motility, and osmotically drawing water into the intestines.
Osmotic or saline laxatives, like magnesium hydroxide or milk of...
Osmotic or saline laxatives, like magnesium hydroxide or milk of...
122
Drugs Affecting GI Tract Motility: Adsorbents as Antidiarrheal Agents
144
Diarrhea is characterized by the occurrence of frequent, watery bowel movements. Various factors can trigger diarrhea, including viral or bacterial infections, foodborne illnesses, side effects from certain medications, and underlying digestive disorders. If not adequately managed, diarrhea can lead to complications such as dehydration, electrolyte imbalances, and nutrient deficiencies. Severe diarrhea can lead to significant weight loss, malnutrition, and weakened immune function.
Adsorbents...
Adsorbents...
144
Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents
126
Diarrhea, a condition marked by frequent loose or watery bowel movements, can be triggered by multiple factors such as viral or bacterial infections, food intolerances, anxiety, medications, and digestive disorders. Symptoms may include abdominal pain, bloating, nausea, and cramping. Severe or prolonged diarrhea can lead to complications like electrolyte imbalances, malnutrition, and dehydration if left untreated.
Opioids, widely used antidiarrheal agents, mitigate diarrhea by slowing down...
Opioids, widely used antidiarrheal agents, mitigate diarrhea by slowing down...
126
Drugs for Treatment of Constipation-Predominant IBS
109
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
109
Drugs Affecting GI Tract Motility: Bulk-Forming and Stimulant Laxatives
133
Laxatives enhance bowel movements and alleviate constipation. They augment the stool's bulk, stimulate intestinal muscle contractions, draw water into the intestines, or soften the stool. There are five key types of laxatives: bulk laxatives, stimulant laxatives, osmotic laxatives, stool softeners, and lubricant laxatives.
Bulk-forming laxatives, such as psyllium, methylcellulose, and polycarbophil, absorb water in the intestine, increasing stool bulk and promoting bowel movement. This...
Bulk-forming laxatives, such as psyllium, methylcellulose, and polycarbophil, absorb water in the intestine, increasing stool bulk and promoting bowel movement. This...
133
Drugs for Treatment of Diarrhea-Predominant IBS
117
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
117


